Tesamorelin

$27.50

Tesamorelin is a research-use-only GHRH analog commonly referenced in studies involving
growth-hormone pathway signaling, IGF-1-related biomarkers, metabolic-response models,
lipid-metabolism research, and body-composition-related analysis.

Secure checkout. Available card and bank-payment options are confirmed at checkout.

Add to Wishlist
Add to Wishlist
Categories: , Tags: , , Product ID: 1676

Research catalog profile

Tesamorelin

Tesamorelin is a research-use-only GHRH analog commonly referenced in studies involving
growth-hormone pathway signaling, IGF-1-related biomarkers, metabolic-response models,
lipid-metabolism research, and body-composition-related analysis.

Catalog reference Product ID 1676
Catalog classification ,
Strength 10mg
Intended context Research use only
Research topics

Use the product selector above to confirm the exact strength and configuration before adding this catalog item to your order.

Quality documentation

Review documentation for Tesamorelin

Available laboratory documentation is organized in the Kanaklyx COA library. Before relying on a report, confirm that the compound name, labeled strength, and lot or batch identifier match the product supplied.

Review COA Library

Match these details

  • Compound name
  • Labeled strength
  • Lot or batch identifier
  • Laboratory and report date

Only use documentation that clearly corresponds to the item and batch being reviewed.

Description

Tesamorelin is a research-use-only synthetic analog of growth-hormone-releasing hormone
commonly studied in laboratory and clinical-research settings involving GHRH receptor
signaling, growth-hormone pathway analysis, IGF-1-related biomarkers, and
metabolic-response research models.

It is often referenced in exploratory research related to body-composition models,
visceral-adipose-tissue research, lipid-metabolism biomarkers, endocrine-signaling pathways,
and age-associated metabolic pathway analysis.

This compound is intended strictly for laboratory and research applications. It is not intended for
human or animal consumption, administration, diagnosis, treatment, prevention, or cure of any
disease.

Sources & References

A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation

2005 • PMID: 16052083 • DOI: 10.1097/01.aids.0000180099.35146.30

View Source →

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension

2010 • PMID: 20101189 • DOI: 10.1097/QAI.0b013e3181cbdaff

View Source →

Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial

2014 • PMID: 25038357 • DOI: 10.1001/jama.2014.8334

View Source →

Efficacy and Safety of Tesamorelin in People with HIV on Integrase Inhibitors

2025 • PMID: 38905488

View Source →

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials

2026 • PMID: 41545261 • DOI: 10.1016/j.orcp.2026.01.002

View Source →

Additional information

Strength

10mg

Tesamorelin
$27.50

Secure checkout. Available card and bank-payment options are confirmed at checkout.

Add to Wishlist
Add to Wishlist